Cellular Biomedicine Group Inc (NASDAQ:CBMG)

Data as of 11:20am ET
 +0.06 / +0.35%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Cellular Biomedicine Group, Inc. is a biomedicine company. It engages in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The company's developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Cellular Biomedicine Group was founded on February 6, 2013 and is headquartered in Palo Alto, CA.

Contact Information

Cellular Biomedicine Group, Inc.
530 University Avenue
Palo Alto California 94301
P:(650) 566-5064
Investor Relations:



Individual stakeholders17.91%
Mutual fund holders0.19%
Other institutional0.06%

Top Executives

Wei CaoPresident, CEO, Chief Operating Officer & Director
Bizuo LiuChief Financial Officer & Secretary
Maxwell WangDirector-Medical Research
Mingyuan ZhouChief Scientist
Li ZhangVice President-Technology & Manufacturing

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.